These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3753261

  • 1. Quantitative histopathology of the inflammatory myopathies.
    Ringel SP, Carry MR, Aguilera AJ, Starcevich JM.
    Arch Neurol; 1986 Oct; 43(10):1004-9. PubMed ID: 3753261
    [Abstract] [Full Text] [Related]

  • 2. [Inflammatory myopathies: diagnosis and classifications].
    Dimitri D.
    Presse Med; 2009 Oct; 38(7-8):1141-63. PubMed ID: 19282137
    [Abstract] [Full Text] [Related]

  • 3. The pathological diagnosis of specific inflammatory myopathies.
    Carpenter S, Karpati G.
    Brain Pathol; 1992 Jan; 2(1):13-9. PubMed ID: 1341942
    [Abstract] [Full Text] [Related]

  • 4. Polymyositis: an overdiagnosed entity.
    van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, Dinant HJ, Linssen WH, Wokke JH, de Visser M.
    Neurology; 2003 Aug 12; 61(3):316-21. PubMed ID: 12913190
    [Abstract] [Full Text] [Related]

  • 5. Proliferative response of peripheral blood mononuclear cells to autologous and allogeneic muscle in patients with polymyositis/dermatomyositis.
    Kalovidouris AE, Pourmand R, Passo MH, Plotkin Z.
    Arthritis Rheum; 1989 Apr 12; 32(4):446-53. PubMed ID: 2706028
    [Abstract] [Full Text] [Related]

  • 6. RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.
    Suárez-Calvet X, Gallardo E, Pinal-Fernandez I, De Luna N, Lleixà C, Díaz-Manera J, Rojas-García R, Castellví I, Martínez MA, Grau JM, Selva-O'Callaghan A, Illa I.
    Arthritis Res Ther; 2017 Jul 24; 19(1):174. PubMed ID: 28738907
    [Abstract] [Full Text] [Related]

  • 7. Clinical, immunopathologic, and therapeutic considerations of inflammatory myopathies.
    Dalakas MC.
    Clin Neuropharmacol; 1992 Oct 24; 15(5):327-51. PubMed ID: 1423335
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inflammatory and toxic myopathies.
    Dalakas MC.
    Curr Opin Neurol Neurosurg; 1992 Oct 24; 5(5):645-54. PubMed ID: 1327303
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ, Mhiri C, Chazaud B, Christov C, Cherin P, Barlovatz-Meimon G, Gherardi RK.
    Neuropathol Appl Neurobiol; 1997 Apr 24; 23(2):132-40. PubMed ID: 9160898
    [Abstract] [Full Text] [Related]

  • 18. [Histological data in inflammatory myositis].
    Mikol J, Polivka M.
    Ann Med Interne (Paris); 2001 Nov 24; 152(7):465-79. PubMed ID: 11965088
    [Abstract] [Full Text] [Related]

  • 19. Pathophysiology of inflammatory and autoimmune myopathies.
    Dalakas MC.
    Presse Med; 2011 Apr 24; 40(4 Pt 2):e237-47. PubMed ID: 21411269
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.